Showing results (381-390 of 404) with videos related to

Sort By:
Pageof 41
Diabetologia|November 1, 1994
Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based studyC F Verge, N J Howard, M J Rowley, et al.
Scandinavian Journal of Rheumatology|January 1, 1997
The effect of HLA-DRB1 disease susceptibility markers on the expression of RAM J Rowley, A Stockman, C A Brand, et al.
Journal of Gastroenterology|February 1, 1996
Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosisK Omagari, M J Rowley, J A Jois, et al.
Clinical Immunology and Immunopathology|February 1, 1995
Differing frequency of autoantibodies to glutamic acid decarboxylase among Koreans, Thais, and Australians with diabetes mellitusT Tuomi, P Zimmet, M J Rowley, et al.
International Angiology : a Journal of the International Union of Angiology|March 24, 2011
The Scottish-Finnish-Swedish PARTNER study of taprostene versus placebo treatment in patients with critical limb ischemiaJ J F Belch, S Ray, M Rajput-Ray, et al.
Cancer Research|August 1, 1990
Pharmacokinetics, tissue distribution, and cell localization of [35S]methionine-labeled recombinant human and murine alpha interferons in miceT G Johns, J A Kerry, B A Veitch, et al.
Diabetologia|February 25, 2005
Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)T M E Davis, A D Wright, Z M Mehta, et al.
Blood|November 9, 2000
Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6-independent phenotype by murine plasmacytomas and hybridomasR Rawat, G J Rainey, C D Thompson, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis and evaluation of benzannelated-azatoxins: the benzazatoxinsT A Miller, P R Vachaspati, M A Labroli, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2000
The synthesis, in vitro reactivity, and evidence for formation in humans of 5-phenyl-1,3-oxazinane-2,4-dione, a metabolite of felbamateC D Thompson, T A Miller, M T Barthen, et al.
Pageof 41